Nine Square Therapeutics Company
Nine Square Therapeutics is discovering new small-molecule therapeutics for degenerative movement disorders including Parkinson’s disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative disorders such as essential tremor and dyskinesias, by integrating computational chemistry, biophysics, and computational biology into machine-learning-enabled cell profiling platforms for target identification, chemical optimization, and patient stratification.
It was founded in 2020 and headquartered in New York, United States.
Total Funding:
54500000
Founded Date:
2020-01-01
Industry:
Quantum Chemistry
Employee Number:
11-50
Last Funding Date:
2023-09-12
Funding Status:
private
Headquarters:
New York,New York,United States,North America
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
54500000
Last Funding Total Usd:
4500000
Last Funding Total Currency:
USD
Last Funding Total Value:
4500000
Founders:
Lani Wu,Matthew Jacobson,Spiros Liras,Steven Altschuler